Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.71 - $1.25 $859,663 - $1.51 Million
1,210,794 Added 120.03%
2,219,532 $1.69 Million
Q4 2022

Feb 14, 2023

BUY
$0.75 - $2.24 $371,580 - $1.11 Million
495,441 Added 96.52%
1,008,738 $970,000
Q3 2022

Nov 14, 2022

SELL
$2.09 - $4.5 $10,126 - $21,802
-4,845 Reduced 0.94%
513,297 $1.12 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $5.28 $412,190 - $806,060
152,663 Added 41.77%
518,142 $1.81 Million
Q1 2022

May 16, 2022

BUY
$4.29 - $6.64 $19,197 - $29,714
4,475 Added 1.24%
365,479 $1.83 Million
Q4 2021

Feb 14, 2022

SELL
$5.77 - $7.96 $165,068 - $227,719
-28,608 Reduced 7.34%
361,004 $2.2 Million
Q3 2021

Nov 12, 2021

SELL
$6.67 - $9.8 $222,958 - $327,584
-33,427 Reduced 7.9%
389,612 $3.28 Million
Q2 2021

Aug 16, 2021

BUY
$5.06 - $10.78 $1.13 Million - $2.4 Million
222,868 Added 111.34%
423,039 $3.17 Million
Q1 2021

May 17, 2021

BUY
$5.64 - $23.33 $21,516 - $89,003
3,815 Added 1.94%
200,171 $1.21 Million
Q4 2020

Feb 16, 2021

SELL
$3.5 - $7.98 $14,805 - $33,755
-4,230 Reduced 2.11%
196,356 $1.12 Million
Q3 2020

Nov 16, 2020

BUY
$4.78 - $16.97 $15,621 - $55,457
3,268 Added 1.66%
200,586 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$1.68 - $8.85 $331,494 - $1.75 Million
197,318 New
197,318 $1.75 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $86M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.